# A Study of LY3209590 in Japanese Participants With Type 2 Diabetes

> **NCT03603704** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 31 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LY3209590
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03603704
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-17
- **Primary completion:** 2019-05-27
- **Final completion:** 2019-05-27
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03603704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03603704, "A Study of LY3209590 in Japanese Participants With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03603704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*